Open AccessBlood component therapy: Which, when and how much
Author(s) -
Rajesh Arya,
GS Wander,
Pankaj Gupta
Publication year - 2011
Publication title -
journal of anaesthesiology-clinical pharmacology/journal of anaesthesiology clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.466
H-Index - 32
eISSN - 2231-2730
pISSN - 0970-9185
DOI - 10.4103/0970-9185.81849
Subject(s) - medicine , blood component , intensive care medicine , perioperative , blood transfusion , adverse effect , component (thermodynamics) , blood management , clinical trial , surgery , physics , thermodynamics
Blood transfusion refers to the perioperative administration of blood and blood components. Adherence to proper indications for blood component therapy is essential because of its potential adverse effects and costs of transfusion. Over the years, the significance of blood components in treating certain diseases or conditions has been recognized. In this article, the most commonly used blood components along with the new developments in component therapy have been discussed. Recommendations by different academic and clinical trials and studies have been presented for quick reference. The individual coagulation factors are discussed in brief.